Karin Travers
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 8
- Viral gastroenteritis research and epidemiology 2
- Virology 9
- HIV Research and Treatment 9
- Co-authors
- Michael Barza (2 shared papers)Phyllis J. Kanki (10 shared papers)Souleymane Mboup (7 shared papers)Aïssatou Guèye‐Ndiaye (4 shared papers)Richard Marlink (7 shared papers)Max Essex (6 shared papers)Tidiane Siby (4 shared papers)Ibrahima Ndoye (3 shared papers)
- Journals
- Science (5 papers)Clinical Infectious Diseases (3 papers)International Journal of Gynecological Cancer (2 papers)Value in Health (2 papers)ClinicoEconomics and Outcomes Research (1 paper)
- Partner nations
- United StatesSenegalUnited Kingdom
In The Last Decade
Karin Travers
33 papers receiving 2.0k citations
Karin Travers's Hit Papers
Peers
Comparison fields: 5 of 111
- Virology 1.0k
- Infectious Diseases 803
- Applied Microbiology and Biotechnology 49
- Molecular Medicine 126
- Otorhinolaryngology 57
Countries citing papers authored by Karin Travers
This map shows the geographic impact of Karin Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Travers more than expected).
Fields of papers citing papers by Karin Travers
This network shows the impact of papers produced by Karin Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Travers. The network helps show where Karin Travers may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Travers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1 Hit paper breakdown → | 1994 | 468 |
| 2 | 1994 | 282 | |
| 3 | 1999 | 184 | |
| 4 | 1995 | 166 | |
| 5 | 2002 | 151 | |
| 6 | 2014 | 122 | |
| 7 | 2011 | 121 | |
| 8 | 2002 | 106 | |
| 9 | 1987 | 90 | |
| 10 | 1992 | 84 | |
| 11 | 2005 | 55 | |
| 12 | 2016 | 33 | |
| 13 | 1996 | 29 | |
| 14 | 2002 | 29 | |
| 15 | 2013 | 20 | |
| 16 | 2019 | 19 | |
| 17 | 2012 | 18 | |
| 18 | 2000 | 15 | |
| 19 | 2013 | 13 | |
| 20 | 2017 | 12 |
About Karin Travers
Karin Travers is a scholar working on Infectious Diseases, Virology, Oncology, Epidemiology and Reproductive Medicine, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (8 papers), Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (4 papers), Sex work and related issues (3 papers), Viral gastroenteritis research and epidemiology (2 papers), T-cell and Retrovirus Studies (2 papers) and Adolescent Sexual and Reproductive Health (2 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (803 citations), Applied Microbiology and Biotechnology (49 citations), Molecular Medicine (126 citations) and Otorhinolaryngology (57 citations). Karin Travers has collaborated with scholars based in United States, Senegal and United Kingdom. Frequent co-authors include Michael Barza, Phyllis J. Kanki, Souleymane Mboup, Aïssatou Guèye‐Ndiaye, Richard Marlink, Max Essex, Tidiane Siby, Ibrahima Ndoye, Ibou Thior and Jean‐Louis Sankalé. Their work appears in journals such as Science, Clinical Infectious Diseases, International Journal of Gynecological Cancer, Value in Health and ClinicoEconomics and Outcomes Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.